BeStock  
Stocks › HALO

Halozyme Therapeutics HALO

US equityMarket cap rank #776
$108.92 −$1.49 (-1.35%)
Market open · Oct 1, 3:30 pm ET · After hours $110.00 -0.36%
Open$109.93
Prev close$110.40
Day range$107.86 – $110.49
Volume1.48M
Market cap$12.36B
P/E (TTM)31.9
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$103.83-4.7% vs. price
  • Buy 83%
  • Hold 17%
Low $93.00Now $108.92Avg $103.83High $115.00

Recent rating changes

The last 20 actions on file set price targets from $57.00 to $115.00, averaging $98.05.

DateFirmRatingTarget
3 Sep 2026 H.C. Wainwright BUY $115.00
2 Sep 2026 H.C. Wainwright BUY $115.00
18 Aug 2026 H.C. Wainwright BUY $115.00
17 Aug 2026 H.C. Wainwright BUY $115.00
7 Aug 2026 TD Cowen BUY $105.00
7 Aug 2026 Wells Fargo HOLD $95.00
7 Aug 2026 Citizens JMP BUY $93.00
7 Aug 2026 Morgan Stanley BUY $105.00
7 Aug 2026 Leerink Partners BUY $110.00
7 Aug 2026 H.C. Wainwright BUY $115.00
6 Aug 2026 TD Cowen BUY $105.00
6 Aug 2026 Wells Fargo HOLD $95.00
21 Jul 2026 H.C. Wainwright BUY $95.00
16 Jun 2026 H.C. Wainwright BUY $95.00
15 Jun 2026 Wells Fargo HOLD $75.00
15 Jun 2026 Morgan Stanley BUY $93.00
14 Jun 2026 Goldman Sachs SELL $57.00
13 May 2026 Wells Fargo HOLD $75.00
12 May 2026 Morgan Stanley BUY $93.00
12 May 2026 H.C. Wainwright BUY $95.00

Discussion

No comments yet — be the first to weigh in on HALO.

Leave a comment

Scroll to Top